Eplontersen for treating hereditary transthyretin-related amyloidosis

  • Technology appraisal guidance
  • TA1020
  • Published: 

Register as a stakeholder

History

Documents created during the development process.

Expected publication

Final draft guidance

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6337